Arcutis Biotherapeutics Market Sentiment

Arcutis Biotherapeutics Inc

ARQTNASDAQ

Trade with Public

$26.54

0.933.63%

가까이에: Aug 17, 5:00 PM EST

$26.58

0.973.77%

프리마켓: 7:02 AM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Arcutis Biotherapeutics Market Sentiment

Market sentiment signals for Arcutis Biotherapeutics (ARQT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.8% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$31

+16.6%

Highest Price Target

$50

+88.1%

Cantor Fitzgerald

Lowest Price Target

-69.9%

HC Wainwright & Co.

Short Interest

10.8%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 6, 2026	Morgan Stanley	Vikram Purohit—	+43.0%	$34 → $38	Maintained	Overweight
Aug 6, 2026	Guggenheim	Seamus Fernandez—	+43.0%	$35 → $38	Maintained	Buy
Aug 6, 2026	Needham	Serge Belanger—	+50.5%	$36 → $40	Maintained	Buy
May 7, 2026	Needham	Serge Belanger—	+35.5%	$36 → $36	Maintained	Buy
Mar 2, 2026	Mizuho	Uy Ear—	+31.7%	$37 → $35	Maintained	Outperform
Feb 27, 2026	Guggenheim	Seamus Fernandez—	+31.7%	$34 → $35	Maintained	Buy
Feb 26, 2026	TD Cowen	Tyler Van Buren—	+31.7%	$30 → $35	Maintained	Buy
Feb 26, 2026	HC Wainwright & Co.	Douglas Tsao—	+27.9%	$30 → $34	Maintained	Buy
Feb 26, 2026	Needham	Serge Belanger—	+35.5%	$31 → $36	Maintained	Buy
Jan 26, 2026	Needham	Serge Belanger—	+16.6%	$30 → $31	Maintained	Buy
Nov 28, 2025	Mizuho	Uy Ear—	+39.2%	$32 → $37	Maintained	Outperform
Oct 30, 2025	Goldman Sachs	Richard Law—	+9.1%	$19 → $29	Maintained	Neutral
Oct 28, 2025	Needham	Serge Belanger—	+12.9%	$22 → $30	Maintained	Buy
Aug 7, 2025	Needham	Serge Belanger—	-17.2%	$20 → $22	Maintained	Buy
Jul 25, 2025	Goldman Sachs	Richard Law—	-32.3%	$18	Initiate	Neutral
May 23, 2025	Needham	Serge Belanger—	-24.7%	$20 → $20	Maintained	Buy
Apr 9, 2025	Needham	Serge Belanger—	-24.7%	$20 → $20	Maintained	Buy
Apr 3, 2025	Guggenheim	Seamus Fernandez—	—	—	Maintained	Buy
Apr 3, 2025	HC Wainwright & Co.	Douglas Tsao—	-28.5%	$19 → $19	Maintained	Buy
Apr 3, 2025	Needham	Serge Belanger—	-24.7%	$20 → $20	Maintained	Buy
Mar 11, 2025	Jefferies	Kambiz Yazdi—	-28.5%	$16 → $19	Maintained	Buy
Feb 27, 2025	Goldman Sachs	Jonathan Block—	-43.6%	$13 → $15	Maintained	Neutral
Feb 26, 2025	HC Wainwright & Co.	Douglas Tsao—	-28.5%	$19 → $19	Maintained	Buy
Feb 26, 2025	Mizuho	Uy Ear—	-21.0%	$20 → $21	Maintained	Outperform
Feb 26, 2025	Needham	Serge Belanger—	-24.7%	$20 → $20	Maintained	Buy